Interferon‐alpha up‐regulates bcl‐2 expression and protects B‐CLL cells from apoptosis in vitro and in vivo
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary. The bcl‐2 oncoprotein, which is involved in the t(14.18) translocation, protects cells against apoptosis. We examined the effects of interferon‐alpha (IFN‐α) on bcl‐2 protein expression and apoptosis in B‐chronic lymphocytic leukaemia (B‐CLL) cells. None of 12 patients with B‐CLL examined expressed the t(14,18) translocation; however, all these, and seven other patients, expressed significant levels of bcl‐2 protein. In vitro, IFN‐α (500U/ml over 18 h) increased bcl‐2 expression on CLL cells (to 200±23% of control MCF, as determined by indirect immunofluorescence and flow cytometry. n = 10, P < 0.001). All of eight patients who received IFN‐α (3 megaunits subcutaneously three times a week) demonstrated an increase in bcl‐2 expression on circulating malignant cells. CLL cells undergo apoptotic cell death when cultured in vitro (35.6 ± 10.3% DNA fragmentation after 18 h, n = 10). In the presence of IFN‐α, however, DNA fragmentation was reduced to 6.6 ± 5.8% (n = 10, P < 0.001). IFN‐α also protected CLL cells against apoptosis induced by hydrocortisone and gamma irradiation (reducing DNA fragmentation from 63.9 ± 12.6% to 10.8 ± 4.5 % and from 80 ± 2.9% to 5.4 ± 1.6%, respectively, P < 0,001 for both). The protective effect of IFN‐α was dose dependent, and maintained for up to 24 h. Our data demonstrate that bcl‐2 expression and apoptosis of CLL cells can be influenced by cytokines. In addition, it seems unlikely that the observed clinical responses to IFN‐a in patients with CLL are due to a direct effect on the malignant cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.6961 · Cited by 1,252
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213 · cited 1×
“Transgenic mice expressing the bcl2-immunoglobuli mini-gene demonstrate an accumulation of polyclonal, small resting B cells that express IgM/IgD, 9 7% of which are in Go/G1 of the cell cycle (McDonnell et al, 1989, 1990).”
BackgroundNuñez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J. P., & Korsmeyer, S. J. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3602 · Cited by 899
Cited by
Tumor microenvironment and therapeutic response
Wu, T., & Dai, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.01.043 · Cited by 1,802
Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C., & Stryckmans, P. (1998) · Blood · doi:10.1182/blood.v91.7.2387 · Cited by 413
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Zhang, W., Trachootham, D., Liu, J., Chen, G., Pelicano, H., Garcia-Prieto, C., Lu, W., Burger, J. A., Croce, C. M., Plunkett, W., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2432 · Cited by 357
Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy
Ioannou, Y., & Isenberg, D. A. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200007)43:7<1431::aid-anr3>3.0.co;2-e · Cited by 252
Regulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding Protein
Gabriele, L., Phung, J., Fukumoto, J., Segal, D., Wang, I.-M., Giannakakou, P., Giese, N. A., Ozato, K., & Morse, H. C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.411 · Cited by 114
“The capability of type I and type II IFNs to modulate the expression of genes belonging to the Bcl-2 family is a controversial issue (66, 67 ).”
Background
Metadata
- Authors
- Jewell, A. P., Worman, C. P., Lydyard, P. M., Yong, K. L., Giles, F. J., & Goldstone, A. H.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1994-10
- Volume
- 88
- Issue
- 2
- Pages
- 268-274
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2045795253
- Cited by
- 107
- References
- 4
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferon‐alpha up‐regulates bcl‐2 expression and protects B‐CLL cells from apoptosis in vitro and in vivo. https://app.cochat.ai/papers/10.1111/j.1365-2141.1994.tb05017.x
- The paper
- Jewell, A. P., Worman, C. P., Lydyard, P. M., Yong, K. L., Giles, F. J., & Goldstone, A. H. (1994). Interferon‐alpha up‐regulates bcl‐2 expression and protects B‐CLL cells from apoptosis in vitro and in vivo. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.1994.tb05017.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.